Retinal vascular occlusive disease and tilt-table inversion

2019 ◽  
Vol 1 (6) ◽  
pp. 352
Author(s):  
Tyler Kaplan ◽  
Bruce Kaplan
Keyword(s):  
Occlusive Disease ◽  
Tilt Table ◽  
Vascular Occlusive Disease

The Results of Superficial Femoral, Popliteal, and Tibial Artery Stenting for Peripheral Vascular Occlusive Disease

2005 ◽  
Vol 71 (11) ◽  
pp. 905-910 ◽  
Author(s):  
Joe H. Morgan ◽  
Charles E. Wall ◽  
D. Benjamin Christie ◽  
Richard L. Harvey ◽  
Maurice M. Solis
Keyword(s):  
Limb Salvage ◽  
Ankle Brachial Index ◽  
Primary Patency ◽  
Occlusive Disease ◽  
Primary Therapy ◽  
Peripheral Vascular Occlusive Disease ◽  
Stage Renal Disease ◽  
End Stage ◽  
Angioplasty And Stenting ◽  
Vascular Occlusive Disease

The purpose of this study was to evaluate the patentcy rates and physiological effectiveness of angioplasty and stenting as a primary therapy for superficial femoral (SFA), popliteal (POP), and tibial (TIB) arterial occlusive disease. Seventy-eight patients had stents placed in the infra-inguinal vessels between January 1, 2001, and July 31, 2004. We collected data on patient demographics, symptoms, as well as pre- and postprocedure ankle-brachial index (ABI) and angio-graphic findings. Patency rates at 6 months, 12 months, and 24 months were analyzed by life table methods. Thirty-one men and 47 women had a mean age of 68 years (range 36–94 years). Risk factors included diabetes in 50 per cent, hypertension in 79 per cent, smoking in 41 per cent, and end-stage renal disease in 10 per cent. The indications for intervention were claudication in 52 per cent and limb salvage in 48 per cent of patients. Stents were placed in the SFA in 54 patients (69%), in the POP in 15 patients (18%), and in the TIB artery in 6 patients (8%). Average follow-up was 11.2 months. The mean postprocedural increase in ABI was 0.29. The 6-month, 1-year, and 2-year primary patency rates were 83 per cent, 58 per cent, and 47 per cent, respectively. Limb salvage was achieved in 66 per cent of patients treated for limb-threatening ischemia. There was one major and three minor complications. Stenting of the infra-inguinal vessels has a low morbidity, high success rate, and acceptable patency and limb-salvage rates.

Hyperhomocysteinemia and Premature Vascular Occlusive Disease

1998 ◽  
Vol 315 (4) ◽  
pp. 279-285
Author(s):  
Susan C. Guba ◽  
Louis M. Fink ◽  
Vivian Fonseca
Keyword(s):  
Occlusive Disease ◽  
Vascular Occlusive Disease

Prevalence of Hyperhomocysteinemia in Vascular Disease: Comparative Study of Thrombotic Venous Disease Vis-è-Vis Occlusive Arterial Disease

Vascular ◽  
2007 ◽  
Vol 15 (3) ◽  
pp. 149-153 ◽  
Author(s):  
Seema Bhargava ◽  
Rajiv Parakh ◽  
Anjali Manocha ◽  
Arif Ali ◽  
Lalit Mohan Srivastava
Keyword(s):  
Venous Thrombosis ◽  
Arterial Occlusion ◽  
Arterial Disease ◽  
Arterial Occlusive Disease ◽  
Occlusive Disease ◽  
Venous Disease ◽  
The North ◽  
Peripheral Vascular Occlusive Disease ◽  
Long Term Follow Up ◽  
Vascular Occlusive Disease

Studies on hyperhomocysteinemia in vascular occlusive disease have included mostly patients with arterial occlusion. However, more recent studies have included cases of venous occlusive disease as well. Our present study is aimed at comparing the prevalence of hyperhomocysteinemia in venous occlusive disease vis-è-vis arterial occlusive disease in the North Indian urban population. Homocysteine was estimated by chemiluminescent immunoassay in 205 normal controls and 536 patients, 244 presenting with arterial occlusion and 292 with venous thrombotic disease. The mean homocysteine in patients with arterial occlusion was 21.79 ± 0.09 μmol/L (mean ± standard error of measurement), in patients with venous thrombosis was 25.53 ± 0.1 μmol/L, and in controls was 11.33 ± 0.18 μmol/L. The prevalence of hyperhomocysteinemia (> 15 μmol/L) was 56.38% in arterial occlusive disease and 54.64% in venous thrombosis. In patients with peripheral vascular occlusive disease, patients with deep venous thrombosis (DVT) had the highest mean homocysteine level (25.51 μmol/L), which was even higher (32.14 μmol/L) when associated with pulmonary embolism (PE). There is a high prevalence of hyperhomocysteinemia in arterial and venous occlusive disease. Hence, in all patients with vascular occlusive disease, hyperhomocysteinemia should be elucidated and treated. In addition, long-term follow-up is required to ascertain whether the reduction in homocysteine decreases the thrombotic events and whether homocysteine levels can actually be of prognostic or predictive value in cases of DVT with PE.

Cocaine-Induced Peripheral Vascular Occlusive Disease

Angiology ◽  
1998 ◽  
Vol 49 (3) ◽  
pp. 221-224 ◽  
Author(s):  
John D. England ◽  
William C. Krupski ◽  
Amparo Gutierrez
Keyword(s):  
Occlusive Disease ◽  
Peripheral Vascular ◽  
Peripheral Vascular Occlusive Disease ◽  
Vascular Occlusive Disease
Sign in / Sign up

Export Citation Format

Share Document